TerrAscend (STU:TED) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 25, 2026)


STU:TED TerrAscend Corp STU:TED
38 GF Score
Price €0.56
GF Value €0.85
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is TerrAscend Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

TerrAscend's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

STU:TED vs ZTS: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, TerrAscend's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TerrAscend Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TerrAscend's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where TerrAscend's Margin of Safety % (DCF Earnings Based) falls into.


STU:TED
38GF Score
TerrAscend Corp STU:TED
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is TerrAscend (STU:TED) Overvalued in 2026?

Based on GuruFocus' analysis, TerrAscend stock appears to be undervalued. The current stock price of €0.56 is trading 34.5% below its estimated GF Value™ of €0.85. GuruFocus considers TerrAscend to be Possible Value Trap.

Key valuation signals for STU:TED:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: €0.85 vs. price of €0.56 (34.5% below fair value)
  • GF Score™: 38/100 with 5 warning signs

No single metric tells the full story. See the STU:TED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TerrAscend Business Description

Other Exchanges TSNDF:USATSND:Canada
Address 77 City Centre Drive, Suite 501, East Tower, Mississauga, ON, CAN, L5B 1M5
TerrAscend Corp is a company focused on creating and delivering cannabis products and services that meet the evolving needs of its patients. It also provides education and support programs to physicians and patients through healthcare professionals. In addition, the firm operates in California, Maryland, New Jersey, and Pennsylvania, with retail operations in Ohio and Canada. It operates The Apothecarium and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. The firm has one operating segment, being the cultivation, production, and sale of cannabis products, with subsidiaries located in Canada and the United States. The company generates key revenue from the United States.
38GF Score

Get the complete analysis for STU:TED

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.56
Price
€0.85
GF Value